InXile Entertainment
inXile Entertainment
| Type | Private |
|---|---|
| Headquarters | Newport Beach, California |
| Key people | Brian Fargo (CEO) |
| Industry | Video game industry |
| Products | Video games |
| Website | [inXile Entertainment Official website] |
inXile Entertainment is an American video game developer based in Newport Beach, California. The company was founded in 2002 by Brian Fargo, who was previously the founder of Interplay Entertainment. inXile Entertainment is known for developing role-playing games (RPGs) and has a reputation for creating games with deep narratives and engaging gameplay.
History
Brian Fargo founded inXile Entertainment in 2002 after leaving Interplay Entertainment. The company initially focused on developing games for the PC and console markets. One of their early projects was "The Bard's Tale", a remake of the classic 1985 game of the same name.
In 2012, inXile Entertainment launched a successful Kickstarter campaign to fund the development of "Wasteland 2", a sequel to the 1988 game "Wasteland". The campaign raised over $2.9 million, making it one of the most successful video game crowdfunding projects at the time. "Wasteland 2" was released in 2014 to critical acclaim.
Following the success of "Wasteland 2", inXile continued to use crowdfunding to support their projects. They launched another successful Kickstarter campaign for "Torment: Tides of Numenera", a spiritual successor to the classic RPG "Planescape: Torment". The game was released in 2017 and received positive reviews for its storytelling and world-building.
In 2018, inXile Entertainment was acquired by Microsoft and became part of Xbox Game Studios. This acquisition provided the company with additional resources and support to develop new projects.
Games Developed
- The Bard's Tale (2004)
- Wasteland 2 (2014)
- Torment: Tides of Numenera (2017)
- The Bard's Tale IV: Barrows Deep (2018)
- Wasteland 3 (2020)
External Links
References
InXile Entertainment Logo
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
